Interstitial lung disease (ILD) is a broad term for a group of conditions that cause lung inflammation and/or fibrosis (scarring). Lung damage from ILD can make breathing difficult, leading to ...
Background Patients with interstitial lung disease (ILD) are at risk of developing nocturnal hypoxaemia due to ventilatory restriction and impaired gas exchange that worsen with supine posture and ...
Interstitial lung disease (ILD) is a group of more than 200 lung disorders that can cause damage and scarring to these organs. Over time, the effects of these diseases can limit your breathing and ...
Idiopathic Pulmonary fibrosis (IPF) is a subset of interstitial lung diseases, where in the normal ageing of lung is augmented. It is characterised by fibrosis of the lung architecture which ...
Interstitial lung disease (ILD) is a collective term for afflictions of the tissues around the air sacs in the lungs, and often presents as a shortness of breath or dry cough. Prolonged ...
Nerandomilast is under clinical development by Boehringer Ingelheim International and currently in Phase III for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). According to GlobalData, ...